Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation. - Wikidata - wikimedia - TriplyDB

Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation.

Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation.

http://www.wikidata.org/entity/Q34125054

about

Understanding the role of B cells in atherosclerosis: potential clinical implications The influence of innate and adaptive immune responses on atherosclerosis The role of T and B cells in human atherosclerosis and atherothrombosis Inflammatory mediators in vascular disease: identifying promising targets for intracranial aneurysm research B cells and atherosclerosis.Artery Tertiary Lymphoid Organs Control Multilayered Territorialized Atherosclerosis B-Cell Responses in Aged ApoE-/- Mice.B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.B2 cells suppress experimental abdominal aortic aneurysms.B cell subsets in atherosclerosis.B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction.B cells and humoral immunity in atherosclerosis Cutting edge: Dexamethasone potentiates the responses of both regulatory T cells and B-1 cells to antigen immunization in the ApoE(-/-) mouse model of atherosclerosis.BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice B-1a lymphocytes attenuate insulin resistance The mutual interplay of lipid metabolism and the cells of the immune system in relation to atherosclerosis Preparation of Single Cell Suspensions from Mouse Aorta Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques.A Recombinant Human Anti-Platelet scFv Antibody Produced in Pichia pastoris for Atheroma Targeting.Adaptive immunity in atherogenesis: new insights and therapeutic approaches.Immune effector mechanisms implicated in atherosclerosis: from mice to humans.TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases.Bone marrow-specific knock-in of a non-activatable Ikkα kinase mutant influences haematopoiesis but not atherosclerosis in Apoe-deficient mice.Accelerated atherosclerosis in SLE: mechanisms and prevention approaches.Inflammation and immune system interactions in atherosclerosis.Vaccines against atherosclerosis.Molecular biology of atherosclerosis.B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance.Multiple potential roles for B cells in atherosclerosis.Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges.Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis.Macrophages and immune cells in atherosclerosis: recent advances and novel concepts.BAFF receptor and TACI in B-1b cell maintenance and antibacterial responses.Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.Rhein inhibits the expression of vascular cell adhesion molecule 1 in human umbilical vein endothelial cells with or without lipopolysaccharide stimulation.Blockade of B-cell-activating factor signaling enhances hepatic steatosis induced by a high-fat diet and improves insulin sensitivity.The regulation of immune cells by Lactobacilli: a potential therapeutic target for anti-atherosclerosis therapy.High Levels of (Un)Switched Memory B Cells Are Associated With Better Outcome in Patients With Advanced Atherosclerotic Disease.Deficiency of TDAG51 protects against atherosclerosis by modulating apoptosis, cholesterol efflux, and peroxiredoxin-1 expression.Oxidized LDL level is related to gene expression of tumour necrosis factor super family members in children and young adults with familial hypercholesterolaemia.

P2860

Q26991813-AC78F6FC-D3BB-4B19-A0CE-C703992F4125 Q27000370-DE1152E1-4402-497E-9F45-23C19F862710 Q27000791-CAA1F6D9-DB6C-4DD0-8514-3F20BB341FB4 Q28084855-825FEF2C-A54A-43C9-B261-F014470C9E3D Q30252928-025EB1F6-D9C4-45D8-9AE4-0C38412968A3 Q30276940-71E8E752-3248-494B-B17D-A0810A3E61C8 Q30279171-784A50BF-D2B5-4116-BB85-B153431254C4 Q30370021-A2C33235-3291-4ACD-A75A-C3EE8C302060 Q30423324-859A3AC3-CE34-42F6-B01D-B4E2AD511C5C Q33704093-BB867770-D429-4650-A949-08BAF4B0CC5D Q33789638-52A44828-84E1-4262-9A2C-5080969FF245 Q34130293-495EF155-BE61-4EEC-8FD3-A444B9ED58E3 Q34656412-8457E180-FDE0-4148-B6A0-B5F840A15DED Q35004327-5EE9BD2D-D53C-4D05-98E1-95D4B236AEA5 Q35104236-B05AA64E-ED66-4BC0-B2C4-CA200DEFEDEB Q36059694-7F76CDA5-C509-4305-8457-27A03E3FDA5E Q36184299-FB92D303-DD57-4EDF-B84D-5F63E5AA86AA Q36261019-F8938BFE-CDCC-4A58-BE6C-911F1BC1D3AA Q36497196-9CBC17EB-EFCF-45F5-A88F-261E3B402872 Q37150605-2D484863-2FF2-4392-A969-A685070B17F2 Q37494039-DEEB7BEE-310F-479D-94AE-83C45735A052 Q37548680-DF7995E3-B755-4E52-AF68-550119ED269A Q37658524-C6326039-E5B1-41D0-9C9C-834EC9FF6D63 Q38083555-E7EC4649-89CD-4A15-8CD2-90067365D4BD Q38089941-18326904-27B1-48DB-B6C7-1BD9C4E34DDF Q38125279-355A0ACA-FF77-4949-AFB6-15296EFA2FF4 Q38152732-D2E477ED-7BFC-4C51-871C-1505B89D5D53 Q38210609-0C2987C0-895F-4C2D-A48B-107CCB735929 Q38265002-C8FFC9B5-0344-416C-920F-D62283E4EB97 Q38346930-DFF6320B-1765-4BDB-BE8E-4E376A6E21FE Q38406177-C1526989-15BA-4F0E-ADDD-53908BE17F22 Q38462573-B9AB5EF4-B567-4899-B91A-17E5D8ED8C05 Q38472786-D49D2308-C55C-4C64-9476-86DC8B97E70A Q38774904-5A607F26-5B66-49A7-AE0D-BE99DB253469 Q39147048-3C83F3FA-20D7-4915-9B9E-2FDCD2A2D969 Q39210681-4CAA1159-C9F9-4348-B07A-960CBCFA2AE6 Q41709158-F7D1E490-703C-47C7-AEFA-8990962B0A51 Q42373676-CDDDA99B-5261-479F-BADD-7F6BF7F50450 Q43109046-34F95C87-4607-4B23-9E23-69E550676457 Q46224491-E615B03D-7B97-4144-AB1D-CB9A1738C4A2

P2860

Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE mice attenuates atherosclerosis by potently ameliorating arterial inflammation.

http://www.wikidata.org/entity/Q34125054

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Depletion of B2 but not B1a B ...... orating arterial inflammation.

@ast

Depletion of B2 but not B1a B ...... orating arterial inflammation.

@en

Depletion of B2 but not B1a B ...... orating arterial inflammation.

@nl

type

label

Depletion of B2 but not B1a B ...... orating arterial inflammation.

@ast

Depletion of B2 but not B1a B ...... orating arterial inflammation.

@en

Depletion of B2 but not B1a B ...... orating arterial inflammation.

@nl

altLabel

Depletion of B2 but Not B1a B ...... iorating Arterial Inflammation

@en

prefLabel

Depletion of B2 but not B1a B ...... orating arterial inflammation.

@ast

Depletion of B2 but not B1a B ...... orating arterial inflammation.

@en

Depletion of B2 but not B1a B ...... orating arterial inflammation.

@nl

P1433

Q34125054-E33265F6-3C98-478F-97FB-1A6BF58D8F75

P1476

Q34125054-C5645F0A-DC3B-4EF8-8B0F-3C8106F683B8

P2093

Q34125054-0B6952F6-9294-4D70-B39C-5FAC0095E740

Q34125054-0CC68056-6F00-47DA-9EB3-7AEBDD9CC8DF

Q34125054-25F60630-4668-4AD1-AFC2-318D5711ED5C

Q34125054-66F143AA-1D81-4C74-80A6-17F7A72176B3

Q34125054-6F6A1D89-3DAF-4C2D-BC0C-D8A60B9DE37F

Q34125054-7F95739D-90C0-4802-AA07-352BC05FD555

Q34125054-8D26D6AC-66D0-4699-89D8-B2F9B0829E4E

Q34125054-E7CD7CEC-DDFD-46BD-81B4-C09E23A4FB5A

P2860

Q34125054-044AAF96-702C-4C5C-9AD3-78C52BEFE4B8

Q34125054-1849CDE1-963F-4FF9-A7A4-B08515BBCC2A

Q34125054-186F275D-3DF5-47C9-B181-EE7D1EF749C6

Q34125054-1F014CC1-901D-4F55-B3A5-CBB56F66E7A8

Q34125054-1F8B696B-0E23-4FEE-903A-8659A9FC16AB

Q34125054-265C283E-FF1A-497C-82B3-53D4D2B4CD92

Q34125054-2D770C4E-E3CB-48C0-8B82-B89548F7D3BA

Q34125054-2ECC714C-FB81-4004-BA5F-58D99130C7DC

Q34125054-312EAFE5-296B-474F-8A87-81F15B65FAE6

Q34125054-34B2FFB4-AE03-4E25-8427-A3A9E48DAFBF

P304

Q34125054-CFA89B14-FF78-40B0-BE3A-BAADFA2A024C

P31

Q34125054-5DEC7C49-08C3-4562-8E9D-64406472A8E0

P356

Q34125054-1333A6E6-B392-431A-9CE0-3F48EFC7717F

P407

Q34125054-F4AB4873-D6C4-45FA-BA5B-1AC4BA6BD23D

P433

Q34125054-16E838C1-C240-45DC-97D5-092AE6B59692

P478

Q34125054-D1EDAE1D-0A13-4C59-A759-706E6138C7C2

P50

Q34125054-630E19A2-A95F-4A22-AC2F-6FD59D370633

P577

Q34125054-3DF93469-4EBA-429A-9B25-C4A80818046A

P5875

Q34125054-6024C055-3A81-40BE-A812-C905533C77CF

P698

Q34125054-0E89BCE9-5883-407A-8724-F8BBBC3F9DA7

P921

Q34125054-2AA24048-118B-4208-8383-512F22E0BFB8

Q34125054-9BC5326C-B2D5-40F3-9B03-41AD7DE87DF1

P932

Q34125054-D2C2D67F-1EF4-45E8-99AC-AE9F57BA1C69

P356

JOURNAL.PONE.0029371

P1433

P1476

Depletion of B2 but not B1a B ...... orating arterial inflammation.

@en

P2093

Alex Bobik

http://www.w3.org/2001/XMLSchema#string

Ban-Hock Toh

http://www.w3.org/2001/XMLSchema#string

Christopher Tay

http://www.w3.org/2001/XMLSchema#string

Fabeinne MacKay

http://www.w3.org/2001/XMLSchema#string

Hamid Hosseini

http://www.w3.org/2001/XMLSchema#string

Peter Kanellakis

http://www.w3.org/2001/XMLSchema#string

Peter Tipping

http://www.w3.org/2001/XMLSchema#string

Tahlia Gadowski

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

BAFF-R, a newly identified TNF receptor that specifically interacts with BAFF

DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL

Regulation of B cell self-tolerance by BAFF

Functional and clinical aspects of the B-cell-activating factor (BAFF): a narrative review

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

A major role for VCAM-1, but not ICAM-1, in early atherosclerosis

Normal induction but attenuated progression of germinal center responses in BAFF and BAFF-R signaling-deficient mice

B cell-activating factor belonging to the TNF family (BAFF)-R is the principal BAFF receptor facilitating BAFF costimulation of circulating T and B cells

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

P304

e29371

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0029371

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221741557

http://www.w3.org/2001/XMLSchema#string

P698

22238605

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

3251583

http://www.w3.org/2001/XMLSchema#string